Key result
This paper is a study protocol for a systematic review and meta-analysis, and therefore contains no clinical results.
Why the study?
Findings regarding the impact of statins on endothelial function in type 2 diabetes mellitus have been contradictory across randomized controlled trials.
Do statins improve endothelial function in adults with type 2 diabetes mellitus?
Systematic Review
Do statins improve endothelial function in adults with type 2 diabetes mellitus?
This protocol outlines a planned systematic review and meta-analysis to evaluate the impact of statins on endothelial function in adults with type 2 diabetes.
Protocol for statin-endothelial function review in T2DM; leaves open whether statins improve function or biomarkers are therapeutic targets.
BACKGROUND: Due to contradicting findings on impact of statins on endothelial function in type 2 diabetes mellitus especially across the randomized controlled trials (RCTs). With this systematic review, we aim to evaluate whether the use of statins improves endothelial function in adults with type 2 diabetes. We will further highlight if these biomarkers are ideal therapeutic targets for risk for atherosclerosis and cardiovascular disease. METHODS: This protocol was carried out according to the preferred reporting items for systematic review and meta-analysis protocols-2015 guideline. The online databases, such as MEDLINE, Scopus, and Web of Sciences, will be targeted using the medical subject heading terms (MeSH) and text words. The review will include clinical studies on the effect of statins on markers of endothelial function in type 2 diabetes. The Cochrane risk of bias guideline will be used to assess the quality and risk of bias. We are planning to use the grading of recommendation assessment, development, and evaluation approach to evaluate the strength and quality of evidence. RESULTS: This study will not involve human samples and patient data; hence ethics approval will not be required. The findings will be presented in journal clubs and conferences and published in peer-reviewed journals.
No takes yet. Share an insight, caveat, or question.
Mokgalaboni et al. (2022) conducted a systematic review in Type 2 diabetes mellitus. Statins vs. Placebo or healthy participants was evaluated on Endothelial function (VCAM-1, ICAM-1, and FMD). This paper is a study protocol for a systematic review and meta-analysis, and therefore contains no clinical results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: